SEC Form 4 · accession 0001209191-18-007258
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathryn A. Torres
Officer — SVP-Payer Contracting & Align.
Period of report
Jan 31, 2018
Accepted (ET)
Feb 2, 2018 · 8:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2018 | M | 4,300 | $22.95 | A | 4,856 | D | |
| Common Stock | Jan 31, 2018 | M | 7,750 | $37.18 | A | 12,606 | D | |
| Common Stock | Jan 31, 2018 | F | 5,871 | $101.16 | D | 6,735 | D | |
| Common StockF1 | Feb 2, 2018 | S | 5,000 | $100.9328 | D | 1,735 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $22.95 | Jan 31, 2018 | M | 4,300 | D | — | Feb 8, 2022 | Common Stock | 4,300 | 0 | D |
| Stock Appreciation RightF3 | $37.18 | Jan 31, 2018 | M | 6,250 | D | — | Feb 6, 2023 | Common Stock | 6,250 | 0 | D |
| Stock Appreciation RightF4 | $37.18 | Jan 31, 2018 | M | 1,500 | D | — | Feb 6, 2023 | Common Stock | 1,500 | 4,437 | D |
| Stock Appreciation RightF5 | $101.16 | Jan 31, 2018 | A | 18,300 | A | Jan 31, 2019 | Jan 31, 2028 | Common Stock | 18,300 | 18,300 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.9256 to $100.9341, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.
- F3The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
- F4The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
- F5The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.